Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-452
Closed -$34.2K 443
2026
Q1
$34.2K Hold
452
0.02% 230
2025
Q4
$33.7K Hold
452
0.02% 216
2025
Q3
$30.5K Hold
452
0.02% 238
2025
Q2
$30.2K Buy
+452
New +$27.1K 0.02% 234

Other funds holding HOLX

Fairscale Capital's HOLX Position: Q2 2026 in Review

Fairscale Capital sold out of Hologic (HOLX) in Q2 2026, closing a stake of 452 shares — an estimated $34.2K sold.

Fairscale Capital first reported a position in HOLX in Q2 2025 and held it in 4 quarters. The position peaked at $34.2K in Q1 2026. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Fairscale Capital reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Fairscale Capital sold 452 Hologic shares in Q2 2026, an estimated $34.2K.
  • Fairscale Capital first reported a position in Hologic in Q2 2025 and held it in 4 quarters.
  • Fairscale Capital's Hologic position peaked at $34.2K in Q1 2026.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Fairscale Capital's 13F filing for Q2 2026, filed 7 Aug 2026.